Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 530 M534 M529 M466 M556 M560 M 2.11 B Research & development —————— — Operating income 197 M229 M268 M379 M239 M316 M 1.2 B Non-Operating Income, Total -15 M12 M15 M-12 M-26 M15 M -8 M Interest expense, net of interest capitalized 19 M19 M19 M23 M23 M24 M 89 M Non-Operating Income, excl. Interest Expenses -34 M-7 M-4 M-35 M-49 M-9 M -97 M Unusual income/expense —————— — Pretax income 369 M372 M467 M1.09 B405 M503 M 2.47 B Equity in earnings 13 M-6 M27 M22 M18 M38 M 105 M Taxes 43 M55 M53 M80 M48 M68 M 249 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 154 M174 M215 M299 M191 M248 M 953 M Discontinued operations —————— — Net income 154 M174 M215 M299 M191 M248 M 953 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 154 M174 M215 M299 M191 M248 M 953 M Basic earnings per share (Basic EPS) 1.842.072.583.592.292.99 11.45 Diluted earnings per share (Diluted EPS) 1.842.072.583.592.292.99 11.45 Average basic shares outstanding 83.8 M83.5 M83.4 M83.5 M83.3 M83 M — Diluted shares outstanding 83.8 M83.5 M83.4 M83.5 M83.3 M83 M — EBITDA 284 M308 M346 M452 M320 M398 M 1.52 B EBIT 279 M303 M341 M432 M315 M393 M 1.48 B Cost of revenue 965 M1.01 B1.35 B1.06 B906 M1 B 4.32 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 5 M5 M5 M20 M5 M5 M 35 M